[NANOSTRING TECHNOLOGIES, INC.]
European UPC Court of Appeal overturns injunction against NanoString’s CosMx products. NanoString will immediately resume sales in 16 EU member countries.
*View in browser* *NANOSTRING TECHNOLOGIES, INC.*
Press release: March 11, 2024
**
European UPC Court of Appeal overturns injunction against NanoString’s CosMx products. NanoString will immediately resume sales in 16 EU member countries.
*The court has expressed serious doubts about the validity of patents asserted by 10x Genomics in its ongoing litigation with NanoString. * This press release is an English press release issued by NanoString Technologies, Inc. on February 26, 2024.
is being translated into Japanese. The official language of press releases is English, and English takes precedence for their content and interpretation.
Seattle –(BUSINESS WIRE)–
NanoString Technologies, a leading company providing technology for basic and translational research in the life sciences field, Inc. (NASDAQ:
On February 26, 2024, NSTG (hereinafter referred to as “NanoString”) announced that it would be required to comply with the decision made by the Munich Branch of the European Unified Patent Court (hereinafter “UPC”) in September last year against NanoString’s CosMx(TM) Spatial Molecular Imager (SMI). Regarding preliminary injunctions in the EU, The UPC Court of Appeals has announced that this has been overturned. This ruling allows NanoString to immediately resume sales of all CosMx products in the 16 UPC member countries that were under the
preliminary injunction. The court’s detailed judgment states that there are serious concerns that the claims asserted in European Patent 4108782B1 (the “782 Patent”) are invalid, and that “the legal validity of the patent may not be established.” is extremely high.” Single cell spatial analysis using CosMx spatial molecule imager * All CosMx products will be available for sale immediately in 16 UPC member countries *
said Brad Gray, President and CEO of NanoString. “*
In this lawsuit, we have argued from the beginning that the patents asserted against us by 10x and Harvard are invalid. This court’s decision strongly supports our view. *
We would like to thank the UPC Court of Appeals for its detailed consideration of the validity of this patent. *
We feel that our company’s legitimacy has been vindicated by the court’s decision that there is a “very high possibility” that the patent in question is invalid based on prior art. *”
Gray further states: “We believe that the highly questionable lawsuits that 10x has brought against several innovative companies in the market since 2021, including NanoString, stifle competition in the research and technology field and have a negative impact on science and the public interest. We believe this ruling moves in favor of nanostrings and scientific freedom.By seeking invalid and unjustified enforcement of patents, 10x has seriously impeded scientific progress. This caused significant harm to NanoString’s customers, employees, and investors.
NanoString plans to continue to actively pursue this lawsuit and seek damages for the negative impact caused by the plaintiff’s unfair preliminary injunction. But throughout this process, we remain committed to our mission of putting resources toward innovation as opposed to litigation. ”
* As a result of this judgment, the preliminary injunction will be lifted in all 16 UPC member states in the EU. Separately, related European patent 2794928
In a December decision in B1 (the “928 Patent”), Germany’s Munich Higher District Court ordered the lifting of an injunction against the sale of CosMx products in Germany, subject to the payment of a security bond. *
NanoString is considering how to respond next in Germany based on this UPC ruling, and the injunction in Germany is currently pending. * In early February, several prominent scientists published an open letter to Genetic Engineering News (Genetic
Engineering
In an open letter to News), he raised the alarm about the negative impact patent litigation is having on the field of spatial biology and called for antitrust lawsuits. *
NanoString provides the scientific community with an extremely advanced spatial biology tool that combines spatial transcriptomics and spatial proteomics capabilities that exceed any other spatial analysis system. Nanostring CosMx
We are proud that SMI products contribute to medical advances that save lives for patients around the world by helping us understand the genome and its functions and facilitating breakthrough scientific discoveries. CosMx
The SMI platform has been deployed at approximately 180 customer facilities to date.
In Japan, the 113th General Meeting of the Japanese Society of Pathology* will be held from Thursday, March 28th to Saturday, March 30th, 2024 at the Nagoya International Conference Center.*
NanoString will be holding a luncheon seminar on March 28th* From “talking about your dreams” to “making them come true.” Hyplex spatial omics analysis of both transcriptomes and proteins is revolutionizing biology.
About NanoString
NanoString, a leader in spatial biology
Technologies provides an ecosystem of innovative discovery and translational research solutions to help customers map the biological world. The GeoMx(R) Digital Spatial Profiler is a flexible and consistent solution that combines the power of whole tissue imaging with gene expression and protein data for spatial whole
transcriptomics and proteomics.
CosMx(TM)
The Spatial Molecular Imager is a single-cell imaging platform powered by spatial multi-omics that allows researchers to map single cells in their native environment and extract deep biological insights and new discoveries from a single experiment. can. The AtoMx(TM) Spatial Bioinformatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. The nCounter® analysis system, the foundation of our research tools, provides a safe method to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variants with high sensitivity and precision. .
For more information, please visit www.nanostring.com